DALLAS–(BUSINESS WIRE)–Advanced Infusion Care (AIC), a division of AIS Healthcare and a leading provider of personalized infusion therapy, is pleased to announceDALLAS–(BUSINESS WIRE)–Advanced Infusion Care (AIC), a division of AIS Healthcare and a leading provider of personalized infusion therapy, is pleased to announce

New Outpatient Infusion Center Opening in Marietta, GA Expands the National Presence of Advanced Infusion Care

DALLAS–(BUSINESS WIRE)–Advanced Infusion Care (AIC), a division of AIS Healthcare and a leading provider of personalized infusion therapy, is pleased to announce the opening of another Advanced Infusion Care Center (AICC). This latest one is in Marietta, GA represents a significant step forward in AIC’s ongoing expansion and its commitment to increasing access to compassionate, high-quality infusion services across the country.

The opening of more and more AICC sites highlights AIC’s strategic dedication to addressing the rising demand for outpatient infusion therapy. Designed based on a modern, patient-focused approach, the Centers emphasize comfort, convenience, and clinical excellence. Now accepting referrals, the Marietta location is ready to deliver individualized infusion therapy to the patients who depend on these services in the greater Atlanta region.

“We are truly excited to open our new infusion Center in Marietta, GA as it represents another meaningful step in our mission to bring high-quality, personalized care closer to the patients who need it most,” said Simon Castellanos, CEO of AIS Healthcare. “This expansion allows us to better support the community while continuing to raise the standard for outpatient infusion services nationwide.”

Offering a wide range of therapies for both long-term and short-term conditions, AICC—including the Marietta location—ensure that patients have access to the newest FDA-approved treatments. The Centers are built to support diverse clinical needs, with specialties in neurology, gastroenterology, rheumatology, dermatology, immunology, pulmonology, ophthalmology, and endocrinology. In Marietta, patients will find private treatment rooms for added comfort, flexible scheduling options, and highly skilled clinical staff.

“At AIC, we understand that infusion therapy is more than a procedure—it’s an essential part of a patient’s overall health and quality of life,” said Jud Hall, President of AIC. “Our approach is centered on reducing wait times and increasing meaningful care. With private rooms, adaptable appointment options, and highly trained medical professionals, we ensure that every patient receives care designed around their needs.”

As a full-service partner to clinicians, AIC works collaboratively with provider offices, insurance companies, and patients to secure all required authorizations and approvals. Dual accreditation from URAC and the Accreditation Commission for Health Care (ACHC) further sets AIC apart as a trusted leader in infusion care.

About AIS Healthcare

Advancing quality. Improving lives.

As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.

Learn more at aiscaregroup.com.

Contacts

Jud Hall

877.443.4006

Market Opportunity
AI COMPANIONS Logo
AI COMPANIONS Price(AIC)
$0.054209
$0.054209$0.054209
-7.78%
USD
AI COMPANIONS (AIC) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

SEC Delays Crypto Innovation Exemptions, Citing Further Study

SEC Delays Crypto Innovation Exemptions, Citing Further Study

SEC postpones crypto innovation exemptions for blockchain products pending further analysis and congressional input.
Share
CoinLive2026/01/31 11:15
Crypto Market Crash To 6-Month Low Amid Rising Tensions Between Iran and The US

Crypto Market Crash To 6-Month Low Amid Rising Tensions Between Iran and The US

The post Crypto Market Crash To 6-Month Low Amid Rising Tensions Between Iran and The US appeared on BitcoinEthereumNews.com. Key Insights: President Trump induces
Share
BitcoinEthereumNews2026/01/31 11:02
If you put $1,000 in Intel at the start of 2025, here’s your return now

If you put $1,000 in Intel at the start of 2025, here’s your return now

The post If you put $1,000 in Intel at the start of 2025, here’s your return now appeared on BitcoinEthereumNews.com. Intel (NASDAQ: INTC) and Nvidia (NASDAQ: NVDA) announced a new partnership on Thursday, September 18, working on several generations of custom data center and computing chips designed to boost performance in hyperscale, enterprise, and consumer applications. As part of the collaboration, Nvidia, the undisputed leader of the semiconductor sector, will also invest $5 billion in Intel by purchasing its common stock at a price of $23.28 per share. Following the news, Intel stock jumped more than 30% in pre-market trading, while Nvidia saw a 3% uptick, a welcome change following weeks of shaky performance and controversies regarding its Chinese sales. Trading at $31.34 at the time of writing, INTC shares are up 54.99% year-to-date (YTD). INTC YTD stock price. Source: Google Accordingly, a $1,000 investment in the tech company at the start of the year would now be worth $1,549.90, giving you a return of $549.90. ‘The next era of computing’ The move follows a wave of fresh backing for the struggling Intel, including a nearly $9 billion U.S. government purchase of a 10% stake just weeks ago and a $2 billion investment from Japan’s SoftBank. As such, the deal has the potential to put Intel back into the game after years of trying to catch up not just with Nvidia but also AMD (NASDAQ: AMD) and Broadcom (NASDAQ: AVGO). “This historic collaboration tightly couples NVIDIA’s AI and accelerated computing stack with Intel’s CPUs and the vast x86 ecosystem — a fusion of two world-class platforms. Together, we will expand our ecosystems and lay the foundation for the next era of computing,” wrote Nvidia founder and chief executive officer (CEO), Jensen Huang.  However, the U.S. government’s direct involvement suggests that more is at stake than simply propping up Intel, as it likely reflects a broader concern about keeping America competitive…
Share
BitcoinEthereumNews2025/09/18 22:47